Deutsche Raises Price Target on HealthSpring (HS) Following Q3 Results and Cigan (CI) Equity Offering

Deutsche Bank is maintaining its Hold rating on shares of HealthSpring (NYSE: HS) while raising its price target from $43 to $55.

The firm reports it has raised its earnings estimates fro 2011 to 2013 due to the company's third quarter earnings and the recent completion of Cigna's (NYSE: CI) equity offering.

The firm now estimates EPS of $4.30 for FY11, $4.35 for FY12, and $4.60 for FY13. Deutsche's previous estimates for the three years were $4.17, $4.35, and $4.50.

For an analyst ratings summary and ratings history on HealthSpring click here. For more ratings news on HealthSpring click here.

Shares of HealthSpring closed at $54.66 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings
• Yum! Brands (YUM) PT Lowered to $180 at Argus